OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+17.82%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$101M
AUM Growth
+$101M
(-12%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-17.17%
Top 10 Holdings %
Top 10 Hldgs %
88.35%
Holding
28
New
4
Increased
5
Reduced
9
Closed
2
Top Buys
| 1 |
GeneDx Holdings
WGS
|
$8.34M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$4.87M |
| 3 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$2.6M |
| 4 |
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
|
$2.01M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$1.12M |
Top Sells
| 1 |
QuidelOrtho
QDEL
|
$27M |
| 2 |
Moderna
MRNA
|
$5.55M |
| 3 |
Pacific Biosciences
PACB
|
$1.61M |
| 4 |
AGEN
Agenus
AGEN
|
$1.44M |
| 5 |
Opko Health
OPK
|
$565K |
Sector Composition
| 1 | Healthcare | 98.64% |
| 2 | Energy | 0.49% |
| 3 | Industrials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pacific Biosciences
PACB
$393M
| $23.3M | 22.59% |
2,015,495
-139,312
| -6% | -$1.61M |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $17.5M | 16.9% |
196,008
-303,255
| -61% | -$27M |
|
|
3
GeneDx Holdings
WGS
$3.72B
| $9.24M | 8.95% |
25,328,057
+22,838,047
| +917% | +$8.34M |
|
4
Biohaven
BHVN
$1.63B
| $8.68M | 8.4% |
635,476
+28,700
| +5% | +$392K |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.49M | 7.25% |
201,400
+130,947
| +186% | +$4.87M |
|
|
AGEN
6
Agenus
AGEN
$133M
| $6M | 5.8% |
3,945,110
-945,762
| -19% | -$1.44M |
|
7
Forian
FORA
$61.3M
| $5.2M | 5.03% |
1,364,329
+13,072
| +1% | +$49.8K |
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.63M | 4.48% |
555,522
-29,672
| -5% | -$247K |
|
|
9
Opko Health
OPK
$1.1B
| $4.15M | 4.02% |
2,843,165
-387,123
| -12% | -$565K |
|
10
Ardelyx
ARDX
$1.53B
| $3.4M | 3.29% |
709,700
-59,530
| -8% | -$285K |
|
|
DMTK
11
DELISTED
DermTech, Inc. Common Stock
DMTK
| $3.3M | 3.2% |
897,449
+706,680
| +370% | +$2.6M |
|
|
IMMP
12
Immutep
IMMP
$234M
| $2.27M | 2.2% |
1,350,802
-91,523
| -6% | -$154K |
|
|
OMGA
13
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $2.01M | 1.95% |
+333,836
| New | +$2.01M |
|
|
SWTX
14
DELISTED
SpringWorks Therapeutics
SWTX
| $1.12M | 1.08% |
+43,500
| New | +$1.12M |
|
|
AXDX
15
DELISTED
Accelerate Diagnostics
AXDX
| $1.06M | 1.02% |
1,510,654
-117,423
| -7% | -$82.2K |
|
16
ProShares UltraPro QQQ
TQQQ
$26B
| $687K | 0.67% |
140,000
-60,000
| -30% | -$295K |
|
17
Biogen
BIIB
$19.4B
| $671K | 0.65% |
2,412
| – | – |
|
|
VTNR
18
DELISTED
Vertex Energy, Inc
VTNR
| $494K | 0.48% |
+50,000
| New | +$494K |
|
|
VLD
19
DELISTED
Velo3D, Inc.
VLD
| $200K | 0.19% |
+88,266
| New | +$200K |
|
20
Cardinal Health
CAH
$35.5B
| – | – |
0
| – | – |
|
21
Centene
CNC
$14.3B
| – | – |
0
| – | – |
|
22
Day One Biopharmaceuticals
DAWN
$769M
| – | – |
0
| – | – |
|
23
McKesson
MCK
$85.4B
| – | – |
0
| – | – |
|
24
Seres Therapeutics
MCRB
$166M
| – | – |
0
| – | – |
|
|
25
Moderna
MRNA
$9.37B
| – | – |
-30,900
| Closed | -$5.55M |
|